Skip to main content
OpenTrials

Clinical trial condition

Chronic Hepatitis B

Explore clinical trials studying Chronic Hepatitis B. Study availability and eligibility vary by location and protocol.

306 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Chronic Hepatitis B trial results

Completed

A Study Evaluating AHB-137 in Healthy Participants and Participants with Chronic Hepatitis B

NCT05717686

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Stanford Medicine Redwood City, California, United States
  • University of Maryland Baltimore Baltimore, Maryland, United States
  • NYU Langone Health New York, United States
  • American Research Corporation Houston, Texas, United States
View Trial Details
Completed

A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis B

NCT03439488

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Republican Clinical Hospital Chisnau, Moldova
  • Auckland Clinical Services Auckland, New Zealand
  • Seoul National University Hospital Seoul, South Korea
  • Severance Hospital, Yonsei University Health System Seoul, South Korea
View Trial Details
Completed

This is a Phase 1 Study in Which Healthy Volunteers and Participants with Chronic HBV Infection Will Receive HT-101 or Placebo and Will Be Assessed for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity

NCT06746311

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Beijing Ditan Hospital Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital Beijing, Beijing Municipality, China
  • Nanfang Hospital Guangzhou, Guangdong, China
  • The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China
View Trial Details
Completed

Phase 1 Study of HT-102 Administered Subcustaneously in Healthy Participants and Patients with Chronic Hepatitis B for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity (only in Participants with Chronic HBV Infection)

NCT06744686

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou, Fujian, China
  • People's Hospital of Qingyuan Qingyuan, Guangdong, China
  • Luoyang Central Hospital Luoyang, Henan, China
  • The Sixth People's Hospital of Zhengzhou Zhengzhou, Henan, China
View Trial Details

Related conditions